Cellular response to interferon in patients with chronic hepatitis C infection: monitoring the response to improve treatment outcomes.

Trial Profile

Cellular response to interferon in patients with chronic hepatitis C infection: monitoring the response to improve treatment outcomes.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2011 Actual end date (31 Jan 2011) added as reported by UKCRN.
    • 26 Apr 2011 Status changed from recruiting to completed as reported by UKCRN.
    • 12 Nov 2010 United Kingdom Clinical Research Network reports accrual to date changed from 86% to 97%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top